Tower Research Capital (TRC)’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.9K | Sell |
14,578
-7,944
| -35% | -$20.7K | ﹤0.01% | 3208 |
|
|
2025
Q1 | $42.8K | Buy |
22,522
+5,271
| +31% | +$10K | ﹤0.01% | 2332 |
|
|
2024
Q4 | $25K | Buy |
17,251
+12,917
| +298% | +$18.7K | ﹤0.01% | 3026 |
|
|
2024
Q3 | $7.98K | Sell |
4,334
-41,683
| -91% | -$76.7K | ﹤0.01% | 3992 |
|
|
2024
Q2 | $46K | Buy |
46,017
+45,220
| +5,674% | +$45.2K | ﹤0.01% | 3174 |
|
|
2024
Q1 | $1.58K | Sell |
797
-9,418
| -92% | -$18.6K | ﹤0.01% | 5240 |
|
|
2023
Q4 | $15.9K | Buy |
10,215
+4,077
| +66% | +$6.36K | ﹤0.01% | 3800 |
|
|
2023
Q3 | $12.1K | Sell |
6,138
-576
| -9% | -$1.14K | ﹤0.01% | 3925 |
|
|
2023
Q2 | $21.4K | Sell |
6,714
-1,141
| -15% | -$3.63K | ﹤0.01% | 3310 |
|
|
2023
Q1 | $26K | Buy |
7,855
+6,695
| +577% | +$22.2K | ﹤0.01% | 3145 |
|
|
2022
Q4 | $6K | Buy |
+1,160
| New | +$6K | ﹤0.01% | 4695 |
|
|
2022
Q1 | – | Sell |
-3,205
| Closed | -$10K | – | 6132 |
|
|
2021
Q4 | $10K | Buy |
+3,205
| New | +$10K | ﹤0.01% | 4538 |
|